# FDA 483 - James S. Cochran, MD - October 20, 2020

Source: https://www.keypedia.com/records/483/james-s-cochran-md/bb025575-bdfc-476e-8195-945efdc4b1b4

> FDA 483 for James S. Cochran, MD on October 20, 2020. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: James S. Cochran, MD
- Inspection Date: 2020-10-20
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West III
- Summary: James S. Cochran, MD, a clinical investigator in Dallas, TX, was inspected regarding a clinical study. The inspection revealed that the investigation was not conducted according to the signed statement of investigator and investigational plan. This included missed and late collections of urine cytology and missed cystoscopies for study subjects, indicating significant deviations from protocol requirements.

## Related Officers

- [Joanne M. Schlossin](https://www.keypedia.com/people/joanne-m-schlossin/5cb48b8a-d885-4b4f-8c60-d4714d65603d)

Company: https://www.keypedia.com/companies/james-s-cochran-md/4748b3f8-d97c-4572-9a50-e75319f6a4e1

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-iii/2cda09a5-06c4-433f-9df0-0d7903a6efab